228 related articles for article (PubMed ID: 34536046)
21. [The role of alleles with an intermediate number of trinucleotide repeats in Parkinson's disease and other neurodegenerative disorders].
Nikitina MA; Bragina EY; Nazarenko MS; Alifirova VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):42-50. PubMed ID: 35904291
[TBL] [Abstract][Full Text] [Related]
22. The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference.
Murmann AE; Patel M; Jeong SY; Bartom ET; Jennifer Morton A; Peter ME
Cell Death Dis; 2022 Dec; 13(12):1078. PubMed ID: 36585400
[TBL] [Abstract][Full Text] [Related]
23. Huntingtin gene CAG repeat numbers in Chinese patients with Huntington's disease and controls.
Jiang H; Sun YM; Hao Y; Yan YP; Chen K; Xin SH; Tang YP; Li XH; Jun T; Chen YY; Liu ZJ; Wang CR; Li H; Pei Z; Shang HF; Zhang BR; Gu WH; Wu ZY; Tang BS; Burgunder JM;
Eur J Neurol; 2014 Apr; 21(4):637-42. PubMed ID: 24471773
[TBL] [Abstract][Full Text] [Related]
24. Analysis of HTT CAG repeat expansion among healthy individuals and patients with chorea in Korea.
Kim R; Seong MW; Oh B; Shin HS; Lee JS; Park S; Jang M; Jeon B; Kim HJ; Lee JY
Parkinsonism Relat Disord; 2024 Jan; 118():105930. PubMed ID: 37992538
[TBL] [Abstract][Full Text] [Related]
25. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
[TBL] [Abstract][Full Text] [Related]
26. Expansion of a (CAG)n repeat region in a sporadic case of HD.
Bozza A; Malagù S; Calzolari E; Novelletto A; Pavoni M; del Senno L
Acta Neurol Scand; 1995 Aug; 92(2):132-4. PubMed ID: 7484060
[TBL] [Abstract][Full Text] [Related]
27. Uncovering the Genetic and Molecular Features of Huntington's Disease in Northern Colombia.
Ahmad M; Ríos-Anillo MR; Acosta-López JE; Cervantes-Henríquez ML; Martínez-Banfi M; Pineda-Alhucema W; Puentes-Rozo P; Sánchez-Barros C; Pinzón A; Patel HR; Vélez JI; Villarreal-Camacho JL; Pineda DA; Arcos-Burgos M; Sánchez-Rojas M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003344
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
[TBL] [Abstract][Full Text] [Related]
29. Clinical and genetic investigation of a Brazilian family with Huntington's disease.
Agostinho LA; Spitz M; Pereira JS; Paiva CL
Funct Neurol; 2016; 31(3):135-42. PubMed ID: 27678206
[TBL] [Abstract][Full Text] [Related]
30. Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy.
Lee JM; Galkina EI; Levantovsky RM; Fossale E; Anne Anderson M; Gillis T; Srinidhi Mysore J; Coser KR; Shioda T; Zhang B; Furia MD; Derry J; Kohane IS; Seong IS; Wheeler VC; Gusella JF; MacDonald ME
Hum Mol Genet; 2013 Aug; 22(16):3227-38. PubMed ID: 23595883
[TBL] [Abstract][Full Text] [Related]
31. A Novel Triplet-Primed PCR Assay to Detect the Full Range of Trinucleotide CAG Repeats in the Huntingtin Gene (
De Luca A; Morella A; Consoli F; Fanelli S; Thibert JR; Statt S; Latham GJ; Squitieri F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567536
[TBL] [Abstract][Full Text] [Related]
32. Clinical and genetic characteristics in patients with Huntington's disease from China.
Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
[TBL] [Abstract][Full Text] [Related]
33. Huntington's disease genetics.
Myers RH
NeuroRx; 2004 Apr; 1(2):255-62. PubMed ID: 15717026
[TBL] [Abstract][Full Text] [Related]
34. Clinical manifestations of intermediate allele carriers in Huntington disease.
Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
[TBL] [Abstract][Full Text] [Related]
35. Genetic epidemiological characteristics of a Hungarian subpopulation of patients with Huntington's disease.
Despotov K; Zádori D; Veres G; Jakab K; Gárdián G; Tóth E; Kincses TZ; Vécsei L; Ajtay A; Bereczki D; Klivényi P
BMC Neurol; 2021 Feb; 21(1):79. PubMed ID: 33602179
[TBL] [Abstract][Full Text] [Related]
36. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
[TBL] [Abstract][Full Text] [Related]
37. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.
McNicoll CF; Latourelle JC; MacDonald ME; Lew MF; Suchowersky O; Klein C; Golbe LI; Mark MH; Growdon JH; Wooten GF; Watts RL; Guttman M; Racette BA; Perlmutter JS; Ahmed A; Shill HA; Singer C; Saint-Hilaire MH; Massood T; Huskey KW; DeStefano AL; Gillis T; Mysore J; Goldwurm S; Pezzoli G; Baker KB; Itin I; Litvan I; Nicholson G; Corbett A; Nance M; Drasby E; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Al-Hinti J; Moller AT; Ostergaard K; Sherman SJ; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
Mov Disord; 2008 Aug; 23(11):1596-601. PubMed ID: 18649400
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for the onset and progression of Huntington disease.
Chao TK; Hu J; Pringsheim T
Neurotoxicology; 2017 Jul; 61():79-99. PubMed ID: 28111121
[TBL] [Abstract][Full Text] [Related]
39. Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease.
Maat-Kievit A; Helderman-van den Enden P; Losekoot M; de Knijff P; Belfroid R; Vegter-van der Vlis M; Roos R; Breuning M
Am J Med Genet; 2001 Dec; 105(8):737-44. PubMed ID: 11803522
[TBL] [Abstract][Full Text] [Related]
40. An intergenerational contraction of a fully penetrant Huntington disease allele to a reduced penetrance allele: interpretation of results and significance for risk assessment and genetic counseling.
Nahhas F; Garbern J; Feely S; Feldman GL
Am J Med Genet A; 2009 Feb; 149A(4):732-6. PubMed ID: 19267413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
